☆ 4.7 Article

Anti-spike S1 receptor-binding domain antibodies against SARS-CoV-2 persist several months after infection regardless of disease severity

JOURNAL OF MEDICAL VIROLOGY (2021)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

Add to Collection

Article Infectious Diseases

Dynamic anti-spike protein antibody profiles in COVID-19 patients

Yujie Bao et al.

Summary: The study showed that the positive rates of anti-S IgG and IgM were higher in recovered COVID-19 patients compared to in-patients, with more humoral responses targeting CTD-S1 fragments. Early serological screening is less significant as anti-S IgG and IgM do not appear at the onset with decreased T cells.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Medicine, General & Internal

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Roujian Lu et al.

LANCET (2020)

Add to Collection

Article Microbiology

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Michael Letko et al.

NATURE MICROBIOLOGY (2020)

Add to Collection

Article Immunology

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Juanjuan Zhao et al.

CLINICAL INFECTIOUS DISEASES (2020)

Add to Collection

Letter Infectious Diseases

Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients

Yu-Lin Lee et al.

JOURNAL OF INFECTION (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Antibody responses to SARS-CoV-2 in patients with COVID-19

Quan-Xin Long et al.

NATURE MEDICINE (2020)

Add to Collection

Review Medicine, General & Internal

Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19

Kemmian D. Johnson et al.

FRONTIERS IN MEDICINE (2020)

Add to Collection

Letter Infectious Diseases

Occurrence of Acute Pulmonary Embolism in COVID-19-A case series

Davide Fiore Bavaro et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection

Article Virology

Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients

Bertram Flehmig et al.

VIRUSES-BASEL (2020)

Add to Collection

Article Virology

Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study

Xiaoyong Zhang et al.

VIROLOGICA SINICA (2020)

Add to Collection

Article Gerontology

Tocilizumab and corticosteroids for COVID-19 treatment in elderly patients

Flavia Balena et al.

JOURNAL OF GERONTOLOGY AND GERIATRICS (2020)

Add to Collection

Article Medicine, General & Internal

Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge

Limei Liang et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Ania Wajnberg et al.

SCIENCE (2020)

Add to Collection

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients

Nisreen M. A. Okba et al.

EMERGING INFECTIOUS DISEASES (2020)

Add to Collection

© Peeref 2019-2024. All rights reserved.